日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/02/10 | 1,710 | 1,750 | 1,710 | 1,741 | +21 | +1.2% | 8,200 |
| 2026/02/09 | 1,702 | 1,720 | 1,702 | 1,720 | +20 | +1.2% | 3,200 |
| 2026/02/06 | 1,689 | 1,700 | 1,689 | 1,700 | ±0 | ±0% | 3,800 |
| 2026/02/05 | 1,700 | 1,701 | 1,689 | 1,700 | +5 | +0.3% | 3,600 |
| 2026/02/04 | 1,693 | 1,699 | 1,693 | 1,695 | +2 | +0.1% | 900 |
| 2026/02/03 | 1,689 | 1,696 | 1,689 | 1,693 | +4 | +0.2% | 3,700 |
| 2026/02/02 | 1,681 | 1,698 | 1,681 | 1,689 | +9 | +0.5% | 2,700 |
| 2026/01/30 | 1,681 | 1,690 | 1,680 | 1,680 | ±0 | ±0% | 1,000 |
| 2026/01/29 | 1,680 | 1,704 | 1,674 | 1,680 | -21 | -1.2% | 4,800 |
| 2026/01/28 | 1,700 | 1,710 | 1,673 | 1,701 | -4 | -0.2% | 1,700 |
| 2026/01/27 | 1,665 | 1,710 | 1,664 | 1,705 | +25 | +1.5% | 6,300 |
| 2026/01/26 | 1,665 | 1,680 | 1,660 | 1,680 | +3 | +0.2% | 4,500 |
| 2026/01/23 | 1,693 | 1,693 | 1,667 | 1,677 | -16 | -0.9% | 1,100 |
| 2026/01/22 | 1,670 | 1,699 | 1,641 | 1,693 | +27 | +1.6% | 6,900 |
| 2026/01/21 | 1,634 | 1,666 | 1,634 | 1,666 | +19 | +1.2% | 4,700 |
| 2026/01/20 | 1,643 | 1,651 | 1,634 | 1,647 | +4 | +0.2% | 700 |
| 2026/01/19 | 1,639 | 1,656 | 1,635 | 1,643 | +4 | +0.2% | 3,100 |
| 2026/01/16 | 1,652 | 1,670 | 1,619 | 1,639 | -13 | -0.8% | 4,000 |
| 2026/01/15 | 1,636 | 1,670 | 1,635 | 1,652 | +16 | +1% | 4,700 |
| 2026/01/14 | 1,640 | 1,653 | 1,634 | 1,636 | -4 | -0.2% | 1,200 |
| 2026/01/13 | 1,633 | 1,655 | 1,630 | 1,640 | -7 | -0.4% | 5,300 |
| 2026/01/09 | 1,649 | 1,649 | 1,624 | 1,647 | +5 | +0.3% | 2,700 |
| 2026/01/08 | 1,624 | 1,648 | 1,620 | 1,642 | +12 | +0.7% | 6,100 |
| 2026/01/07 | 1,613 | 1,649 | 1,612 | 1,630 | +35 | +2.2% | 4,100 |
| 2026/01/06 | 1,580 | 1,620 | 1,575 | 1,595 | +24 | +1.5% | 3,700 |
| 2026/01/05 | 1,566 | 1,586 | 1,565 | 1,571 | -14 | -0.9% | 500 |
| 2025/12/30 | 1,585 | 1,585 | 1,572 | 1,585 | ±0 | ±0% | 1,800 |
| 2025/12/29 | 1,579 | 1,585 | 1,552 | 1,585 | +2 | +0.1% | 1,700 |
| 2025/12/26 | 1,553 | 1,583 | 1,543 | 1,583 | +31 | +2% | 4,000 |
| 2025/12/25 | 1,565 | 1,565 | 1,510 | 1,552 | +10 | +0.6% | 9,800 |
| 2025/12/24 | 1,559 | 1,559 | 1,537 | 1,542 | -17 | -1.1% | 1,800 |
| 2025/12/23 | 1,533 | 1,559 | 1,533 | 1,559 | +21 | +1.4% | 4,100 |
| 2025/12/22 | 1,544 | 1,554 | 1,532 | 1,538 | +1 | +0.1% | 5,700 |
| 2025/12/19 | 1,540 | 1,543 | 1,530 | 1,537 | -2 | -0.1% | 1,400 |
| 2025/12/18 | 1,535 | 1,539 | 1,530 | 1,539 | +10 | +0.7% | 3,700 |
| 2025/12/17 | 1,530 | 1,536 | 1,520 | 1,529 | +9 | +0.6% | 3,300 |
| 2025/12/16 | 1,531 | 1,531 | 1,520 | 1,520 | -11 | -0.7% | 5,000 |
| 2025/12/15 | 1,528 | 1,532 | 1,525 | 1,531 | +3 | +0.2% | 3,500 |
| 2025/12/12 | 1,528 | 1,528 | 1,522 | 1,528 | +3 | +0.2% | 2,700 |
| 2025/12/11 | 1,535 | 1,535 | 1,525 | 1,525 | -12 | -0.8% | 1,700 |
| 2025/12/10 | 1,550 | 1,550 | 1,535 | 1,537 | -11 | -0.7% | 2,400 |
| 2025/12/09 | 1,540 | 1,555 | 1,532 | 1,548 | +25 | +1.6% | 8,300 |
| 2025/12/08 | 1,530 | 1,531 | 1,523 | 1,523 | -5 | -0.3% | 1,300 |
| 2025/12/05 | 1,525 | 1,537 | 1,525 | 1,528 | +5 | +0.3% | 1,100 |
| 2025/12/04 | 1,529 | 1,530 | 1,523 | 1,523 | -6 | -0.4% | 1,400 |
| 2025/12/03 | 1,539 | 1,541 | 1,529 | 1,529 | -11 | -0.7% | 1,400 |
| 2025/12/02 | 1,543 | 1,550 | 1,529 | 1,540 | +14 | +0.9% | 1,300 |
| 2025/12/01 | 1,539 | 1,540 | 1,526 | 1,526 | -14 | -0.9% | 2,800 |
| 2025/11/28 | 1,523 | 1,540 | 1,522 | 1,540 | +3 | +0.2% | 1,700 |
| 2025/11/27 | 1,538 | 1,540 | 1,521 | 1,537 | +16 | +1.1% | 1,500 |
1～
50
件表示中 / 3881件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 174,100円 | +2.9% | -77.4% | 2.87% | 42.08倍 | 0.33倍 |
|
後発薬中堅、検査薬事業が第２の柱に。提携含めた新薬開発、ベトナムなど海外事業を中期強化 |
| ブライトパス | 6,900円 | -100.0% | - | 0.00% | - | 5.18倍 |
|
久留米大学発創薬ベンチャー。がん向け遺伝子導入ｉＰＳ由来細胞医薬や抗体医薬開発に注力 |
| ＯＴＳ | 2,000円 | +20.0% | - | 0.00% | - | 4.78倍 |
|
がん治療ワクチン創薬ベンチャー。大手製薬と開発提携。東大医科研発。会社計画は非開示 |
| 坪田ラボ | 28,100円 | -85.3% | - | 0.00% | - | 5.61倍 |
|
近視進行抑制、脳活性化などに強いバイオベンチャー。企業との早期契約による収益化で実績 |
| ＰＲＩＳＭＢｉｏ | 19,400円 | -11.4% | - | 0.00% | - | 2.65倍 |
|
独自の創薬基盤技術で細胞内タンパク質間相互作用制御する低分子化合物の創薬ベンチャー |
市場注目の銘柄
チャート関連のコラム
